Filing Details

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

Names of Reporting Persons.

SCG Capital, LLC

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ☐        (b)  ☐

SEC Use Only

Citizenship or Place of Organization

Florida

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

Sole Voting Power

1,074,824*

Shared Voting Power

0

Sole Dispositive Power

1,074,824*

Shared Dispositive Power

0

Aggregate Amount Beneficially Owned by Each Reporting Person

1,074,824*

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐

Percent of Class Represented by Amount in Row (9)

9.99%*

Type of Reporting Person (See Instructions)

OO (Limited Liability Company)

SCG Capital, LLC has rights, under a convertible promissory note, to own an aggregate number of shares of common stock, par value $.001 per share (Common Stock), of BioRestorative Therapies, Inc. (the issuer), which, except for a contractual cap on the amount of outstanding shares of the Common Stock that SCG Capital, LLC may own, could exceed such a cap. SCG Capital, LLCs ownership cap under the convertible promissory note is 9.99% of the outstanding shares of the Common Stock. Therefore, based on 10,453,936 shares of Common Stock outstanding as of November 12, 2018 (as reported on the issuers latest Form 10-Q filed with the Securities and Exchange Commission on November 13, 2018) (10,759,003 shares of Common Stock outstanding giving effect to the shares issuable pursuant to the convertible note, subject to the cap), the number of shares of Common Stock beneficially owned by SCG Capital, LLC as of November 12, 2018 was 1,074,824 shares of Common Stock.

Names of Reporting Persons.

Steven Geduld

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ☐        (b)  ☐

SEC Use Only

Citizenship or Place of Organization

U.S. Citizen

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

Sole Voting Power

1,074,824*

Shared Voting Power

0

Sole Dispositive Power

1,074,824*

Shared Dispositive Power

0

Aggregate Amount Beneficially Owned by Each Reporting Person

1,074,824*

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ☐

Percent of Class Represented by Amount in Row (9)

9.99%*

Type of Reporting Person (See Instructions)

IN

Steven Geduld is the President of SCG Capital, LLC and has indirect beneficial ownership in the securities held by SCG Capital, LLC. SCG Capital, LLC has rights, under a convertible promissory note, to own an aggregate number of shares of Common Stock of the issuer, which, except for a contractual cap on the amount of outstanding shares of the Common Stock that SCG Capital, LLC may own, could exceed such a cap. SCG Capital, LLCs ownership cap under convertible promissory note is 9.99% of the outstanding shares of the Common Stock. Therefore, based on 10,453,936 shares of Common Stock outstanding as of November 12, 2018 (as reported on the issuers latest Form 10-Q filed with the Securities and Exchange Commission on November 13, 2018) (10,759,003 shares of Common Stock outstanding giving effect to the shares issuable pursuant to the convertible note, subject to the cap), the number of shares of Common Stock beneficially owned by SCG Capital, LLC as of November 12, 2018 was 1,074,824 shares of Common Stock.

Name of Issuer:

Address of Issuers Principal Executive Offices:

Name of Persons Filing:

Address of Principal Business Office or, if none, Residence:

Citizenship:

    SCG Capital, LLC

    Steven Geduld

Title of Class of Securities:

CUSIP Number: 090655408

If This Statement Is Filed Pursuant to Rules 13d-1(b), or 13d-2(b), Check Whether the Person Filing Is a:

Ownership.

(a)   Amount Beneficially Owned:

(b)   Percent of Class:

(c)   Number of shares as to whichperson has:

(i) sole power to vote or to direct the vote:

(ii)  shared power to vote or to direct the vote:

(iii)  sole power to dispose or to direct the disposition of:

(iv) shared power to dispose or to direct the disposition of:

Mr. Geduld is the President of SCG Capital and has indirect beneficial ownership in the securities held by SCG Capital. SCG Capital has rights, under a convertible promissory note, to own an aggregate number of shares of common stock, par value $.001 per share (Common Stock), of BioRestorative Therapies, Inc. (the issuer), which, except for a contractual cap on the amount of outstanding shares of the Common Stock that SCG Capital may own, could exceed such a cap. SCG Capitals ownership cap under convertible promissory note is 9.99% of the outstanding shares of the Common Stock. Therefore, based on 10,453,936 shares of Common Stock outstanding as of November 12, 2018 (as reported on the issuers latest Form 10-Q filed with the Securities and Exchange Commission on November 13, 2018) (10,759,003 shares of Common Stock outstanding giving effect to the shares issuable pursuant to the convertible note, subject to the cap), the number of shares of Common Stock beneficially owned by SCG Capital as of November 12, 2018 was 1,074,824 shares of Common Stock.

Ownership of Five Percent or Less of a Class.

Ownership of More than Five Percent on Behalf of Another Person.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Identification and Classification of Members of the Group.

Notice of Dissolution of Group.

Certification.

Exhibit

Number

Description